FN2 Earnings Intelligence
HCA Healthcare, Inc. income statement (quarterly)
HCA Healthcare, Inc. (HCA) Income Statement (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 est. | 12/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $1,060 | $939 | $997 | $940 | $1,013 | - | - |
| + Debt | - | $44,483 | $44,511 | $48,023 | $47,344 | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $18,321 | $18,605 | $19,161 | $19,109 | $20,230 | $19,475 | $19,953 |
| % Growth | - | - | - | - | - | 1.6% | - |
| Gross Profit | - | - | - | - | - | - | - |
| % Margin | - | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - | - |
| % Margin | - | - | - | - | - | - | - |
| Net Income | $1,610 | $1,653 | $1,643 | $1,620 | $1,699 | - | - |
| % Margin | 8.8% | 8.9% | 8.6% | 8.5% | 8.4% | - | - |
| Diluted EPS | $6.45 | $6.83 | $6.96 | $7.15 | $7.62 | $7.01 | $8.13 |
| % Growth | - | - | - | - | - | 0.7% | - |
| Operating Cash Flow | $1,651 | - | - | $2,014 | - | - | - |
| CapEx | $991 | - | - | $1,119 | - | - | - |
| Free Cash Flow | $660 | - | - | $895 | - | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 est. | 12/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $18,321 | $18,605 | $19,161 | $19,109 | $20,230 | $19,475 | $19,953 |
| Gross Profit | - | - | - | - | - | - | - |
| EBITDA | - | - | - | - | - | - | - |
| Net Income | $1,610 | $1,653 | $1,643 | $1,620 | $1,699 | - | - |
| Diluted EPS | $6.45 | $6.83 | $6.96 | $7.15 | $7.62 | $7.01 | $8.13 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $1,060 | $939 | $997 | $940 | $1,013 |
| Short-term Debt | - | $5,104 | $6,110 | $8,532 | $3,890 |
| Long-term Debt | $41,057 | $39,379 | $38,401 | $39,491 | $43,454 |
| Total Debt | - | $44,483 | $44,511 | $48,023 | $47,344 |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1,651 | - | - | $2,014 | - |
| Capital Expenditure | $991 | - | - | $1,119 | - |
| Free Cash Flow | $660 | - | - | $895 | - |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | - | - | - | - | - |
| EBITDA Margin | - | - | - | - | - |
| Net Margin | 8.8% | 8.9% | 8.6% | 8.5% | 8.4% |
| FCF Margin | 3.6% | - | - | 4.7% | - |
| Diluted EPS Growth | - | - | - | - | - |